Octreotide Sandoz (Octreotide Acetate)

Octreotide acetate, the active ingredient in Octreotide Sandoz, is a somatostatin analog presented as a unknown/unknown for unknown use. It treats hormone‑secreting tumours and related endocrine disorders in adults. GNH USA supplies Octreotide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octreotide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octreotide Sandoz is a somatostatin analogue that modulates hormone secretion in several endocrine conditions.

- Acromegaly: reduces excessive growth hormone production and helps control disease activity. - Neuroendocrine tumours: controls the secretion of vaso‑active peptides and alleviates flushing and diarrhoea. - Carcinoid syndrome: diminishes flushing and diarrhoea by inhibiting serotonin release. - Preventive post‑operative bleeding after pancreatic surgery : reduces the risk of haemorrhage by inhibiting vascular growth. - S    

Octce